NCT01264991

Brief Summary

BACKGROUND Osteoarthritis (OA) is the most common form of arthritis and the knee is one of the most affected joints. The meniscus plays an important role in the development of knee OA. It is unclear whether a degenerative meniscus tear is a risk factor in developing knee OA or a sign of the disease. The standard treatment for a degenerative meniscus tear is an arthroscopic partial meniscectomy (APM). There is strong evidence that this puts the knee at high risk of later developing OA. Earlier studies have shown a significant placebo effect from surgical procedures, in general, and an arthroscopic knee procedure, in particular. PURPOSE The overall purpose of this study is to gather information that might lead to a reduction in the development of OA in middle-aged patients. The investigators hypothesise that the benefit from an arthroscopic partial meniscectomy is due to the placebo effect measured on self-reported outcomes, and that the meniscectomy contributes to the development of knee OA as seen on radiography. METHODS The investigators will include 100 patients aged from 35 to 55 years with an MRI-confirmed medial meniscus tear and without knee OA (excluding patients with Grade 3 or 4 knee OA on the Kellgren-Lawrence classification). Participants will be randomised to either a standard APM procedure or a sham procedure and both groups will receive standard post-operative care. The primary outcomes will be a self-reported questionnaire, the KOOS score, and a functionality test after 3 and 24 months.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 22, 2010

Completed
2 months until next milestone

Study Start

First participant enrolled

February 21, 2011

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

October 24, 2017

Status Verified

October 1, 2017

Enrollment Period

4.7 years

First QC Date

December 21, 2010

Last Update Submit

October 23, 2017

Conditions

Keywords

ShamMeniscus tearMeniscectomy

Outcome Measures

Primary Outcomes (1)

  • Knee injury and Osteoarthritis Outcome Score - KOOS

    The primary outcome at 2 years follow-up will be a self-reported questionnaire, the Knee injury and Osteoarthritis Outcome Score (KOOS), comprising five different subscales: 1. pain 2. other symptoms 3. activities in daily living (ADL) 4. function in sport and recreation 5. knee-related quality of life (QOL) A mean of the 5 subscales will be calculated (KOOS5 = \[KOOSpain + KOOSsymptoms + KOOSADL + KOOSsport\&rec KOOSQOL\] / 5. Range 0 to 100, worst to best)

    2 year follow-up

Secondary Outcomes (6)

  • One-leg jump test

    2 year follow-up

  • Knee-bending test

    2 year follow-up

  • Knee extension strength

    2 year follow-up

  • EQ-5D

    2 year follow-up

  • SF-36

    2 year follow-up

  • +1 more secondary outcomes

Study Arms (2)

APM group

EXPERIMENTAL
Procedure: Arthroscopic partial meniscectomy

Sham group

PLACEBO COMPARATOR
Procedure: Sham procedure

Interventions

The arthroscopic partial meniscectomy will be performed on an outpatient basis by experienced surgeons at a level of at least attending physicians or at the last year of residency. All arthroscopies will be performed in general anaesthesia combined with local anaesthesia. After general anaesthesia is induced, the knee will be examined for stability. Thereafter two standard portals on the lateral and medial side of the ligamentum patella will be created but no outflow cannula inserted. An arthroscope will be used with a pressure-controlled irrigation system. Tourniquet use will be according to surgeon preference. The strategy for the meniscectomy will be to preserve as much tissue as possible. A standard operation protocol will be used to document possible findings in cartilage, ligaments, synovium and the medial and lateral meniscus. Meniscus lesions and type of will be registered and changes in the articular cartilage will be classified according to the ICRS classification

APM group

The placebo procedure will be performed under the same conditions as above. The patient will be fully sedated in general anaesthesia. As above, the stability of the knee will be examined. Local anaesthetic will be applied as above and 2 skin incisions will be made at the same location and the same size as above. Then the knee will be manipulated as if a real arthroscopy were being done, the spillage of water and all the other equipment needed for an arthroscopy will be used and manipulated. No instruments will enter the portals for arthroscopy to avoid the possibility of osteochondral lesions and unwanted interventions by the surgeon.

Sham group

Eligibility Criteria

Age35 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with knee pain for more than 2 months without significant trauma (only the index knee will be included)
  • MRI-confirmed medial meniscus lesion (patients with a medial meniscus lesion AND a lateral lesion will also be included)
  • Age 35-55 years\*
  • Eligible for outpatient surgery - ASA score 1-2

You may not qualify if:

  • Patients in need of acute surgery e.g. locking knees, high-energy trauma
  • Symptoms associated with other musculoskeletal co-morbidities overriding the symptoms of the knee
  • Grade 3 or 4 knee OA on the Kellgren-Lawrence classification
  • Knee surgery within the last 2 years
  • Obese patients with BMI \> 35
  • Patients with ischemic heart disease
  • Patients with diabetic late-complications
  • Patients with thrombophilia
  • Pregnancy
  • Patients unable to speak Danish
  • Patients with drug or alcohol abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Næstved Hospital

Næstved, Region Sjælland, 4800, Denmark

Location

Slagelse Hospital

Slagelse, Region Sjælland, 4200, Denmark

Location

Related Publications (3)

  • Roos EM, Hare KB, Nielsen SM, Christensen R, Lohmander LS. Better outcome from arthroscopic partial meniscectomy than skin incisions only? A sham-controlled randomised trial in patients aged 35-55 years with knee pain and an MRI-verified meniscal tear. BMJ Open. 2018 Feb 2;8(2):e019461. doi: 10.1136/bmjopen-2017-019461.

  • Hare KB, Lohmander LS, Roos EM. The challenge of recruiting patients into a placebo-controlled surgical trial. Trials. 2014 May 13;15:167. doi: 10.1186/1745-6215-15-167.

  • Hare KB, Lohmander LS, Christensen R, Roos EM. Arthroscopic partial meniscectomy in middle-aged patients with mild or no knee osteoarthritis: a protocol for a double-blind, randomized sham-controlled multi-centre trial. BMC Musculoskelet Disord. 2013 Feb 25;14:71. doi: 10.1186/1471-2474-14-71.

Study Officials

  • Ewa Roos, Professor

    Research Unit of Musculoskeletal Function and Physiotherapy, Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense

    STUDY CHAIR
  • Kristoffer B Hare, MD

    Dept. of Orthopadeics, Slagelse Hospital, Region Zealand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

December 21, 2010

First Posted

December 22, 2010

Study Start

February 21, 2011

Primary Completion

November 1, 2015

Study Completion

November 1, 2015

Last Updated

October 24, 2017

Record last verified: 2017-10

Locations